People In Brief
This article was originally published in The Gray Sheet
Executive Summary
Cordis head: Johnson & Johnson names Seth H.Z. Fischer company group chairman and worldwide franchise chairman of stent subsidiary Cordis, effective Jan. 1. He replaces Rick Anderson, who is leaving the company. Fischer has headed J&J's North American pharmaceuticals division since 2004 and has been with J&J since 1983. J&J recently announced a corporate restructuring that puts Cordis in the newly formed Comprehensive Care group, which also includes Ortho-Clinical Diagnostics, and the diabetes and vision care units (1"The Gray Sheet" Nov. 19, 2007, p. 11)
You may also be interested in...
J&J Reshuffles Device Biz Into “Surgical” And “Comprehensive Care” Groups
Johnson & Johnson is restructuring its device and diagnostics units as part of a larger reorganization intended to improve internal collaborations and help identify opportunities beyond its existing businesses, the company says
Staar Shakes Up U.S. Sales Force, Separating Cataract And Refractive Teams
Staar Surgical is separating its U.S. refractive and cataract product sales teams as part of a major restructuring intended to reverse the recent decline in the company's domestic revenues
Boehringer Ingelheim Overtakes Bayer As Germany’s Biggest Pharma Company
The privately owned company is searching for a successor to Jardiance, while the outcome of US Inflation Reduction Act talks on price cuts to the blockbuster will be revealed in September.